0.9064USD-0.18%Mkt Cap: 5.51M USDP/E: —Last update: 2026-06-01
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at-home administration without medical profes…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap5.51M USD
Enterprise Value4.47M USD
Revenue (TTM)2.18M USD
Gross Profit153.00K USD
Net Income (TTM)-18.18M USD
Revenue/Share1.520 USD
Last Price0.9064 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees12
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.36
EV/Revenue2.05
P/S2.52
P/B0.10
EPS (TTM)-3.67
EPS (Forward)—
52W Range
0.84000% of range17.40
52W High17.40 USD
52W Low0.8400 USD
Profitability
Gross Margin5.99%
Oper. Margin-568.30%
EBITDA Margin0.00%
Profit Margin-712.30%
ROE-54.29%
ROA-44.22%
Growth
Revenue Growth-36.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.37M USD
CapEx (TTM)60.00K USD
FCF Margin-311.87%
FCF Yield-123.55%
Net Debt-1.02M USD
Net Debt/EBITDA0.08
Balance Sheet
Debt/Equity0.04
Current Ratio0.90
Quick Ratio0.43
Book Value/Sh8.651 USD
Cash/Share0.3670 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateAug 12, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.6.09M
Float5.85M
Insiders5.42%
Institutions1.04%
Short Interest
Short Ratio0.3d
Short % Float3.17%
Short % Out.3.11%
Shares Short163.39K
Short (prev mo.)16.23K
Technical
SMA 501.465 (-38.1%)
SMA 2003.524 (-74.3%)
Beta1.59
S&P 52W Chg27.94%
Avg Vol (30d)541.08K
Avg Vol (10d)313.02K
Technical Indicators
RSI (14)31.8
MACD-0.1520
MACD Signal-0.1573
MACD Hist.+0.0053
BB Upper1.363 USD
BB Middle1.082 USD
BB Lower0.8008 USD
BB Width51.97%
ATR (14)0.1139 USD
Vol Ratio (20d)0.11x